Evidence map›Paper›PMID 42147977›Full record

ArticleChina CDC weekly2026

Stage-Specific Lifestyle Effects on the Dynamic Transitions of Metabolic Multimorbidity - Jiangsu Province, China, 2019-2024.

Yang Ding, Xuan Zhu, Wentao Yao, Xinyuan Ge, Jiahao Zhang, Jing Lu, Jingyi Fan, Pei Qin, Chengxiao Yu, Yun Wang and 8 more

Abstract read
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yang Ding *Department of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Xuan Zhu *Department of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Wentao Yao *Department of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Xinyuan GeDepartment of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jiahao ZhangDepartment of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jing LuHealth Management Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jingyi FanHealth Management Center, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou City, Jiangsu Province, China.
Pei QinHealth Management Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Chengxiao YuHealth Management Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Yun WangHealth Management Center, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou City, Jiangsu Province, China.
Xuehui WangWuxi Medical Center, Nanjing Medical University, Wuxi City, Jiangsu Province, China.
Qingning DuanThe Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou City, Jiangsu Province, China.
Lihua ChengChangzhou Medical Center, Nanjing Medical University, Changzhou City, Jiangsu Province, China.
Chen ZhouChangzhou Medical Center, Nanjing Medical University, Changzhou City, Jiangsu Province, China.
Qun ZhangHealth Management Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Ci SongDepartment of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Hongxia MaDepartment of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Hongbing ShenDepartment of Epidemiology, China International Cooperation Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: The prevalence of metabolic multimorbidity is rising in China and has been linked to lifestyle factors; however, evidence characterizing the dynamic transitions across disease states and the stage-specific influence of lifestyle behaviors remains scarce. What is added by this report?: At baseline, the prevalence of metabolic multimorbidity was 24.14%, with males, older adults, and individuals with adverse lifestyle behaviors bearing a disproportionately elevated risk. Hepatic steatosis was associated with a markedly increased risk of progression to multimorbidity, while smoking, high-salt diets, and irregular physical activity each showed differential associations with specific disease transition pathways. What are the implications for public health practice?: Lifestyle behaviors exert meaningful influence at every stage of metabolic disease progression, identifying them as priority targets for stage-specific prevention and control strategies in China.

Indexed as

LifestyleMetabolic DiseaseMultimorbidity

Identifiers

PMID42147977
PMCPMC13171615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.